{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:43:22Z","timestamp":1770295402291,"version":"3.49.0"},"reference-count":91,"publisher":"Wiley","issue":"s3","license":[{"start":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T00:00:00Z","timestamp":1384214400000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:p>Progress in the development of antivirals for non\u2010influenza respiratory viruses has been slow with the result that many unmet medical needs and few approved agents currently exist. This commentary selectively reviews examples of where specific agents have provided promising clinical benefits in selected target populations and also considers potential therapeutics for emerging threats like the <jats:styled-content style=\"fixed-case\">SARS<\/jats:styled-content> and Middle East respiratory syndrome coronaviruses. Recent studies have provided encouraging results in treating respiratory syncytial virus infections in lung transplant recipients, serious parainfluenza virus and adenovirus infections in immunocompromised hosts, and rhinovirus colds in outpatient asthmatics. While additional studies are needed to confirm the efficacy and safety of the specific agents tested, these observations offer the opportunity to expand therapeutic studies to other patient populations.<\/jats:p>","DOI":"10.1111\/irv.12173","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T09:59:18Z","timestamp":1384250358000},"page":"36-43","source":"Crossref","is-referenced-by-count":38,"title":["Advances in antivirals for non\u2010influenza respiratory virus infections"],"prefix":"10.1111","volume":"7","author":[{"given":"Frederick G.","family":"Hayden","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and International Health Department of Medicine University of Virginia School of Medicine Charlottesville VA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,11,12]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12045"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12049"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029652"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-7-201204030-00411"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis726"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis636"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c4779"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211721"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-66"},{"key":"e_1_2_10_11_1","first-page":"pii=20427","article-title":"Evidence of person\u2010to\u2010person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013","volume":"18","author":"The Health Protection Agency (HPA) UK Novel Coronavirus Investigation team","year":"2013","journal-title":"Euro Surveill"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.2807\/ese.17.40.20290-en"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2010.04.009"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.034983-0"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/095632020601700505"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.05.019"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.4.2.291"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc2452"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030343"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn243"},{"key":"e_1_2_10_21_1","first-page":"399","article-title":"Treatment of severe acute respiratory syndrome with lopinavir\/ritonavir: a multicentre retrospective matched cohort study","volume":"9","author":"Chan KS","year":"2003","journal-title":"Hong Kong Med J"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.2003.012658"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.03.001"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.024588"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/378304"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep01686"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1001"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01410-12"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000756"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.24.3222"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00611-12"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00009-13"},{"key":"e_1_2_10_33_1","unstructured":"BelardoG La FraziaS CenciareliO CartaS RossignolJF SantoroMG.Nitazoxanide a novel potential anti\u2010influenza drug acting in synergism with neuraminidase inhibitors[Internet]. Paper presented at: 49th Infectious Disease Society of America Annual Meeting; 2011 Oct 20\u201323; Boston MA. Available athttp:\/\/idsa.confex.com\/idsa\/2011\/webprogram\/Paper31075.html. IDSA Annual Meeting Boston: New Approaches to Anti\u2010Viral Therapy Saturday October 22 2011. 2012 (Accessed 29 April 2013)."},{"key":"e_1_2_10_34_1","unstructured":"RossignolJF SamudralsS HoppersMet\u00a0al.A randomized double\u2010blind placebo (PCB) controlled clinical trial of nitazoxanide (NTZ) in adults and adolescents with acute uncomplicated influenza[Internet]. Paper presented at: 49th Infectious Disease Society of America Annual Meeting; 2011 Oct 20\u201023; Boston MA. Available athttp:\/\/idsa.confex.com\/idsa\/2011\/webprogram\/Paper33028.html. IDSA Annual Meeting Boston. LB\u201035. 10\u201022\u20102011 (Accessed 29 April 2013)."},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16506-9"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1086\/500143"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-004-1271-9"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki346"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1280"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12005"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00515-12"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1086\/429631"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00554-10"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq025"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60206-1"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.2.179"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2061"},{"key":"e_1_2_10_48_1","first-page":"609","volume-title":"Red Book: 2012 Report of the Committee on Infectious Diseases, 29th","author":"American Academy of Pediatrics","year":"2012"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2060"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-263400"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.12.019"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis516"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1086\/525263"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01961-12"},{"key":"e_1_2_10_55_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2058"},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1811"},{"key":"e_1_2_10_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181a165e4"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1036"},{"key":"e_1_2_10_59_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152612800100143"},{"key":"e_1_2_10_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00014-09"},{"key":"e_1_2_10_61_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2064"},{"key":"e_1_2_10_62_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912186107"},{"key":"e_1_2_10_63_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201003-0422OC"},{"key":"e_1_2_10_64_2","unstructured":"Alnylam presents complete results from phase IIb trial with ALN\u2010RSV01 an inhaled RNAi therapeutic for the treatment of respiratory syncytial virus (RSV) infection. Available athttp:\/\/www.businesswire.com\/news\/home\/20120904005531\/en\/Alnylam-Presents-Complete-Results-Phase-IIb-Trial."},{"key":"e_1_2_10_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.4.1470-1479.2006"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.1086\/522609"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007788"},{"key":"e_1_2_10_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis622"},{"key":"e_1_2_10_69_2","doi-asserted-by":"publisher","DOI":"10.1086\/653621"},{"key":"e_1_2_10_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2012.00718.x"},{"key":"e_1_2_10_71_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir501"},{"key":"e_1_2_10_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12045"},{"key":"e_1_2_10_73_2","doi-asserted-by":"publisher","DOI":"10.3201\/1708.101760"},{"key":"e_1_2_10_74_2","doi-asserted-by":"publisher","DOI":"10.1086\/598521"},{"key":"e_1_2_10_75_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph3103343"},{"key":"e_1_2_10_76_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350901400110"},{"key":"e_1_2_10_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2009.00391.x"},{"key":"e_1_2_10_78_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-259291"},{"key":"e_1_2_10_79_2","doi-asserted-by":"publisher","DOI":"10.1086\/426831"},{"key":"e_1_2_10_80_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0800200105"},{"key":"e_1_2_10_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.09.007"},{"key":"e_1_2_10_82_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05983-11"},{"key":"e_1_2_10_83_2","doi-asserted-by":"publisher","DOI":"10.1086\/375069"},{"key":"e_1_2_10_84_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.11.4492-4499.2005"},{"key":"e_1_2_10_85_2","unstructured":"LambertJN.Rhinovirus both in vitro and in an experimental human infection model. Presented at: 51st Interscience Conference on Antimicrobial Agents and Chemotherapy Annual Meeting; 2011 Sep 17\u201020; Chicago. Presentation V\u20101557\u2010BTA798. ICAAC. 2013."},{"key":"e_1_2_10_86_2","unstructured":"Biota Press Release. HRV phase IIb study achieves primary endpoint. Available atwww.biotapharma.com\/uploaded\/154\/1021819_20hrvp-haseiibstudyachieve.pdf. (Accessed 16 May 2013)"},{"key":"e_1_2_10_87_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198601093140202"},{"key":"e_1_2_10_88_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198601093140201"},{"key":"e_1_2_10_89_2","unstructured":"Synairgen Press Release. Positive phase II asthma clinical trial data. Available athttp:\/\/www.synairgen.com\/media\/1536\/19%20april%202012%20Phase%20II%20press%20release%20final.pdf. (Accessed 16 May 2013)"},{"key":"e_1_2_10_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.02.198"},{"key":"e_1_2_10_91_2","doi-asserted-by":"publisher","DOI":"10.1039\/c2mb05416g"},{"key":"e_1_2_10_92_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033174"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Firv.12173","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.12173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:07:05Z","timestamp":1694556425000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.12173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":91,"journal-issue":{"issue":"s3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1111\/irv.12173"],"URL":"https:\/\/doi.org\/10.1111\/irv.12173","archive":["Portico"],"relation":{},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}